| Product Code: ETC7657627 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Oncology Molecular Diagnostic Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Oncology Molecular Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Oncology Molecular Diagnostic Market - Industry Life Cycle |
3.4 Israel Oncology Molecular Diagnostic Market - Porter's Five Forces |
3.5 Israel Oncology Molecular Diagnostic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Oncology Molecular Diagnostic Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Israel Oncology Molecular Diagnostic Market Revenues & Volume Share, By Test Location, 2021 & 2031F |
3.8 Israel Oncology Molecular Diagnostic Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Israel Oncology Molecular Diagnostic Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Oncology Molecular Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Israel |
4.2.2 Growing adoption of personalized medicine in oncology |
4.2.3 Technological advancements in molecular diagnostics |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for molecular diagnostic tests |
4.3.2 High cost associated with molecular diagnostic tests |
4.3.3 Limited reimbursement policies for molecular diagnostics in Israel |
5 Israel Oncology Molecular Diagnostic Market Trends |
6 Israel Oncology Molecular Diagnostic Market, By Types |
6.1 Israel Oncology Molecular Diagnostic Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.4 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.1.5 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.1.6 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.1.7 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.1.8 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.1.9 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Oncology Molecular Diagnostic Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By Instruments, 2021- 2031F |
6.2.3 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By Reagents, 2021- 2031F |
6.2.4 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Oncology Molecular Diagnostic Market, By Test Location |
6.3.1 Overview and Analysis |
6.3.2 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.3 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By Other Establishments, 2021- 2031F |
6.3.4 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By Point of Care, 2021- 2031F |
6.4 Israel Oncology Molecular Diagnostic Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By PCR, 2021- 2031F |
6.4.3 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By Multiplex, 2021- 2031F |
6.4.4 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.4.5 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By In Situ Hybridization, 2021- 2031F |
6.4.6 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By Isothermal Nucleic Acid Amplification Technology (INAAT), 2021- 2031F |
6.4.7 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By Chips and Microarrays, 2021- 2031F |
6.4.8 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.4.9 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Oncology Molecular Diagnostic Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Israel Oncology Molecular Diagnostic Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
7 Israel Oncology Molecular Diagnostic Market Import-Export Trade Statistics |
7.1 Israel Oncology Molecular Diagnostic Market Export to Major Countries |
7.2 Israel Oncology Molecular Diagnostic Market Imports from Major Countries |
8 Israel Oncology Molecular Diagnostic Market Key Performance Indicators |
8.1 Adoption rate of molecular diagnostic tests in oncology clinics |
8.2 Number of partnerships between diagnostic companies and research institutions |
8.3 Rate of introduction of new molecular diagnostic technologies in the market |
9 Israel Oncology Molecular Diagnostic Market - Opportunity Assessment |
9.1 Israel Oncology Molecular Diagnostic Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Oncology Molecular Diagnostic Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Israel Oncology Molecular Diagnostic Market Opportunity Assessment, By Test Location, 2021 & 2031F |
9.4 Israel Oncology Molecular Diagnostic Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 Israel Oncology Molecular Diagnostic Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Oncology Molecular Diagnostic Market - Competitive Landscape |
10.1 Israel Oncology Molecular Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 Israel Oncology Molecular Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here